GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hemagen Diagnostics HMGN · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Hemagen Diagnostics — daily HMGN Delayed
Market value
$3,099
Last close × shares
Volume
50k
Shares, 30 Oct 2026

About Hemagen Diagnostics

Its shares trade under the ticker HMGN. It has been listed since 4 February 1993. In the fiscal year to 30 September 2012, it reported revenue of $4.0m and a net loss of $907,315. At that date it held total assets of $2.4m and shareholders' equity of −$3.6m.

Hemagen Diagnostics, Inc. is a biotechnology company. The company is headquartered in Columbia, Maryland. The firm is primarily focused on Veterinary Clinical Diagnostics. The company is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. Its assays utilize multiple technologies, including Enzyme Linked Immunosorbent Assay (ELISA), immunofluorescence (IFA) and hemagglutination (HA). Its product, HEMASORB NSD, is designed to remove interfering substances with patient sera. Its product, The HEMASORB G REMOVAL Reagent, is developed to remove interfering immunoglobulin (IgG) antibodies from human sera prior to testing for immunoglobulin M (IgM). The company develops, manufactures and markets test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. Its products are used in laboratories, hospitals and blood banks around the world. Its autoimmune products include Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG and VIRGO ANA/Hep-2 IgG.

Figures and description from our data supplier, not checked against the company's own report.

More about Hemagen Diagnostics →

Latest on Hemagen Diagnostics

Our reporting

We have not reported on Hemagen Diagnostics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Hemagen Diagnostics's ticker?

Hemagen Diagnostics trades as HMGN on its US listing, under ISIN US4235011057.

What was Hemagen Diagnostics's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.